Azitra AZTR
NYSE AZTR
$0.13 +0.00 (+1.92%)
As of: Aug 20, 2026 · 3:59 PM EDT

Azitra (AZTR) Revenue (2022 - 2024)

Azitra's (AZTR) quarterly Revenue came in at $7500.0 in Q2 2024, down 95.64% YoY from $172000.0 in Q3 2023, and down 91.67% on a QoQ basis from $90000.0 in Q4 2023.

Azitra (AZTR) Revenue (2022 - 2024) Analysis & Trends

Azitra (AZTR) has 3 years of Revenue data on file, last reported at $7500.0 in Q2 2024.

  • Quarterly Revenue fell 95.64% year-over-year to $7500.0 in Q2 2024, while the trailing twelve-month figure through Jun 2025 was $7500.0 (down 98.16% YoY) and the FY2024 annual result came in at $7500.0, down 98.91% from the prior year.
  • Revenue eased to $7500.0 in Q2 2024, from $90000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $310700.0 in Q3 2023 to a low of $7500.0 in Q2 2024.
  • A 3-year average of $107187.5 and a median of $87500.0 in 2022 frame the typical range for Revenue.
  • Annual changes were most pronounced in 2023 — Revenue surged 540.62% — and 2024, when it slumped 95.64%.
  • Tracing AZTR's Revenue over 3 years: stood at $30500.0 in 2022, then soared by 195.08% to $90000.0 in 2023, then sank by 91.67% to $7500.0 in 2024.
  • The last three Revenue figures came in at $7500.0 (Q2 2024), $90000.0 (Q4 2023), and $310700.0 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1.52 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.29 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 425.49 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 674.14 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 1.06 Bn
10 Azitra 2.44 Mn 2.44 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 7,500.00
Dec 31, 2023 90,000.00
Sep 30, 2023 310,700.00
Jun 30, 2023 172,000.00
Mar 31, 2023 113,300.00
Dec 31, 2022 30,500.00
Sep 30, 2022 48,500.00
Jun 30, 2022 85,000.00